Skip to main content
. 2021 Jun 15;13(6):6568–6575.

Table 3.

The relative expressions of YAP1 mRNA, E-cadherin mRNA, and vimentin mRNA in the two sets of patients ( ± s)

Group Number of cases YAP1 mRNA E-cadherin mRNA vimentin mRNA
Nasal-polyps group 58 2.107±0.337 0.729±0.164 1.478±0.251
Control group 30 1.264±0.283 1.527±0.301 0.920±0.231
t - 11.721 16.133 10.151
P - 0.000 0.000 0.000